> > Export a strategic pillar

EXPORT

A STRATEGIC PILLAR

"Expansion into international markets demonstrates our commitment to support innovation in ophthalmology through an unparalleled network of specialised partners”

Export, a value creating pillar for Horus Pharma.

For the founders of Horus Pharma, Martine and Claude Claret, growth is based on the international expansion of the group, in order to extend the influence of innovation :

See our subsidiaries

An eye on the international market...

Beginning

International expansion is becoming a key business objective. Though the laboratory’s international expansion began in 2010 in Western Europe, today it takes on a new dimension with the signing of distribution agreements in Eastern Europe and across the Atlantic. . 

First subsidiaries

2015 marks another key milestone for Horus Pharma with the launch of first European subsidiaries.

Netherlands

2017 marks the opening of the third subsidiary with the Netherlands.

Switzerland

2022 marks the continuation of the group's international expansion, with the opening of a new subsidiary, Horus Pharma Suisse.

Convinced that innovation and the sharing of skills transcend borders, Horus Pharma is always looking for new international partners. Are you interested in collaborating ? Feel free to contact us at.

While holding on to our national roots

Though our eye is on the international market, the foundations of Horus Pharma remain firmly anchored in France, where the laboratory has built a strong national network bringing together research sites, academic structures, health institutions, patient associations and manufacturing sites in subcontracting. With over 60% of its annual production units carried out in France, Horus Pharma remains true to its values and its roots, valuing the expertise and local know-how above all, to help bring them together and to offer them international exposure.

See our story